79386527 - MICROCAPS ADARE

Information

• Trademark
• 79386527

• Source

• Serial Number

  79386527

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 21, 2023
  a year ago

• Transaction Date

  May 27, 2025
  9 days ago

• Status Date

  May 12, 2025
  24 days ago

• Location Date

  May 12, 2025
  24 days ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 112

  Employee Name

  SANTOMARTINO, MARTHA

• Attorney Docket Number

  040869

  Attorney Name

  ROBERT S. BRODER

  Law Office Assigned Location Code

  M30

• Owners

  • ADARE PHARMACEUTICALS S.A.S

Case File Statements

• GS0401: Manufacturing services to the order and specification of others of drug dosage forms, drug compositions, drug formulations, drug delivery agents in the nature of tablets, orally disintegrating tablets, minitablets, microtablets, minitablets and microtablets comprising multiparticulates, capsules, lozenges, powders, granules, granulates, sprinkles, sachets, patches, pads, suppositories, creams, gels, ointments, paste, emulsions, suspensions, syrups, elixirs, drops, liquids, skin lotions, vaccines, injectables, aerosols, and sanitary products, all in the pharmaceutical and the veterinary fields; clinical manufacturing of drug compositions for others to support clinical trials
• DM0000: The mark consists of the stylized capitalized wording "MICROCAPS" in white with aquamarine shading, on a rectangular background half in green on the left, fading to the other half in dark blue on the right. There are green ovals of color extending from the left into the blue on the right, and small white ovals of color throughout the green half. The wording "ADARE" in dark blue stylized capital letters appears below, with an aquamarine green circle above and encompassing the top of the second letter "A".
• GS0051: Pharmaceutical, veterinary and sanitary products, namely, drug delivery agents in the form of specialized tablets, orally disintegrating tablets, minitablets, microtablets, minitablets and microtablets comprising multiparticulates, filled capsules, lozenges, powders, granules, granulates, sprinkles, sachets, patches, pads, suppositories, creams, gels, ointments, paste, emulsions, suspensions, syrups, elixirs, drops, liquids, skin lotions, vaccines and injectables used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, bronchoconstriction, thrombocythemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, Alzheimer's, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis; inhalers for medical purposes sold filled with pharmaceutical, veterinary and sanitary preparations for treating asthma, pulmonary hypertension, inflammation of respiratory tract, bronchoconstriction, plasmodium infections and fungal infections
• CC0000: The color(s) white, dark blue, and aquamarine green is/are claimed as a feature of the mark.
• GS0421: Research and development services in the pharmaceutical and the veterinary fields; product design and development of pharmaceutical preparations including powder and granules for suspension in liquids, semisolid forms, solid forms, capsules, tablets, sachets, sprinkles; research and development in the area of drug delivery systems with customized release, taste masked release, controlled release; technological consultancy services in the field of new product development

Case File Event Statements

• 12/28/2023 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 12/29/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/2/2024 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/9/2024 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/2/2024 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 9/24/2024 - 8 months ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/14/2024 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/15/2024 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/2/2024 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/24/2024 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 9/24/2024 - 8 months ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/24/2024 - 8 months ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/16/2024 - 7 months ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 10/16/2024 - 7 months ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 10/16/2024 - 7 months ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 12/5/2024 - 6 months ago

  20 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 12/5/2024 - 6 months ago

  19 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/5/2024 - 6 months ago

  17 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 12/5/2024 - 6 months ago

  16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 12/5/2024 - 6 months ago

  21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/5/2024 - 6 months ago

  18 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/8/2025 - a month ago

  22 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF

• 4/8/2025 - a month ago

  24 - EX PARTE APPEAL-INSTITUTED Type: EXPI

• 4/25/2025 - a month ago

  26 - ASSIGNED TO LIE Type: ALIE

• 4/28/2025 - a month ago

  27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/28/2025 - a month ago

  28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/12/2025 - 24 days ago

  30 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/12/2025 - 24 days ago

  31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/12/2025 - 24 days ago

  29 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/8/2025 - a month ago

  23 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 4/8/2025 - a month ago

  25 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 5/27/2025 - 9 days ago

  32 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 5/27/2025 - 9 days ago

  33 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS